10% Owner Elcan Patricia F acquire 325 shares of HCA Healthcare Inc. [HCA]

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. HCA Healthcare Inc. shares valued at $64,564 were purchased by Elcan Patricia F on Jul 25. At $198.66 per share, Elcan Patricia F acquired 325 shares. The insider’s holdings grew to 89,337 shares worth approximately $17.34 million following the completion of this transaction.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Also, Berres Jennifer sold 2,358 shares, netting a total of over 516,086 in proceeds. Following the sale of shares at $218.87 each, the insider now holds 11,392 shares.

Before that, Whalen Kathleen M had sold 500 shares from its account. In a trade valued at $107,690, the SVP & Chief Ethics Officer traded HCA Healthcare Inc. shares for $215.38 each. Upon closing the transaction, the insider’s holdings decreased to 500 shares, worth approximately $2.21 million.

As published in a research note from BMO Capital Markets on July 06, 2022, HCA Healthcare Inc. [HCA] has been rated down from a Market perform to an Underperform and the price target has been revised to $160 from $233. This represents a -21.29% premium over Thursday’s closing price. Analysts at Loop Capital started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of May 27, 2022, Bernstein has increased its “Mkt perform” rating to a “an Outperform” for HCA. Earlier on March 29, 2022, Wells Fargo initiated its rating. Their recommendation was “an Equal weight” for HCA stock.

Analyzing HCA’s Price Performance

On Thursday, HCA Healthcare Inc. [NYSE: HCA] plunged -2.40% to $194.06. The stock’s lowest price that day was $193.55, but it reached a high of $198.10 in the same session. During the last five days, there has been a drop of approximately -7.13%. Over the course of the year, HCA Healthcare Inc. shares have dropped approximately -24.47%. Shares of the company reached a 52-week high of $279.02 on 04/21/22 and a 52-week low of $164.47 on 07/14/22. A 50-day SMA is recorded $205.11, while a 200-day SMA reached $225.05. Nevertheless, trading volume fell to 1.07 million shares from 0.9 million shares the previous day.

Support And Resistance Levels for HCA Healthcare Inc. (HCA)

According to the 24-hour chart, there is a support level at 192.37, which, if violated, would cause prices to drop to 190.69. In the upper region, resistance lies at 196.92. The next price resistance is at 199.79. RSI (Relative Strength Index) is 36.37 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -9.90, which suggests the price will decrease in the coming days. Percent R is at 98.23%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is HCA Healthcare Inc. subject to short interest?

Stocks of HCA Healthcare Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.49 million shares to 4.57 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 5.06 million shares. A decline of -10.72% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.03 of the overall float, the days-to-cover ratio (short ratio) decline to 2.03.

Which companies own the most shares of HCA Healthcare Inc. (HCA)?

According to The Vanguard Group, Inc. filings, the company currently owns 17,677,324 shares, which is about 6.16% of the total HCA shares outstanding. The investor’s shares have plunged by -441,489 from its previous 13-F filing of 18118813.0 shares. With the completion of the sale transaction, Wellington Management Co. LLP’s stake is now worth $2,756,147,851. Sanders Capital LLC acquire a 14.10% interest valued at $2.2 billion while BlackRock Fund Advisors sold a -553,124 stake. A total of -657,426 shares of HCA Healthcare Inc. were sold by SSgA Funds Management, Inc. during the quarter, and 98,760 were bought by Harris Associates LP. In its current portfolio, T. Rowe Price Associates, Inc. holds 4,951,222 shares valued at $979.7 million.

In terms of HCA Healthcare Inc. share price expectations, FactSet research, analysts set an average price target of $239.48 in the next 12 months, up nearly 20.7% from the previous closing price of $198.84. Analysts anticipate HCA Healthcare Inc. stock to reach $283.00 by 2022, with the lowest price target being $150.00. In spite of this, 26 analysts ranked HCA Healthcare Inc. stock as an Overweight at the end of 2022. On January 10, 2022, Citigroup assigned a price target of “a Buy” to the stock and resumed coverage with a $306.


Please enter your comment!
Please enter your name here